3Nair B, Taylor-Gjevre R. A review of topical diclofenac use in musculoskeletal. Disease[J]. Pharmaceuticals, 2010, 3 (6):1892-1908.
4OConnor KM, Corrigan OI. Comparison of the physicoehemical properties of the N- (2 hydroxyethyl) pyrrolidine, diethylamine and sodium salt forms of diclofenac [J]. Int J Pharm, 2001, 222 (2): 281-293.
5Katrin K, Christel C, Miller G. Diclofenac release from phos- pholipid drug systems and permeation through excised human stratum corneum [J]. Int J Pharm, 1995, 125 (2): 231-242.
6Djordjevic L, Primorac M, Stupar M. In vitro release of diclofe nae diethylamine from caprylocaproyl maerogolglycerides based microemulsions [J]. Int J Pharm, 2005, 296 (1-2) : 73-79.
7国家食品药品监督管理局.标准(试行)YBH20892004双氯芬酸二乙胺乳胶剂[s].
8British Pharmacopoeia Commission. BP2009 [S]. The Stationery Office, 2009: 8631.
